Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Neurobiology of Aging|December 13, 2005
Plasma IGF-I levels and cognitive performance in older womenOlivia Okereke, Jae Hee Kang, Jing Ma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohortsShelley S Tworoger, I-Min Lee, Julie E Buring, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2007
Glioma risk in relation to serum levels of insulin-like growth factorsStefan Lönn, Peter D Inskip, Michael N Pollak, et al.
BMJ (Clinical Research Ed.)|June 2, 2012
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control studyLaurent Azoulay, Hui Yin, Kristian B Filion, et al.
Plos One|November 28, 2012
Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metforminMahvash Zakikhani, Miguel Bazile, Sina Hashemi, et al.
European Urology|May 15, 2016
Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin CancerYi Lian, Hui Yin, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 12, 2022
Biomarkers of Glucose Homeostasis and Inflammation with Risk of Prostate Cancer: A Case-Cohort StudyYing Wang, Susan M Gapstur, Christina C Newton, et al.
Cancer Causes & Control : CCC|May 10, 2017
Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trialLinda M Liao, Jonathan N Hofmann, Eunyoung Cho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Association of markers of insulin and glucose control with subsequent colorectal cancer riskSharon H Saydah, Elizabeth A Platz, Nader Rifai, et al.
BMJ (Clinical Research Ed.)|November 1, 2016
Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research DatalinkBlánaid M Hicks, Hui Yin, Oriana H Y Yu, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Neurobiology of Aging|December 13, 2005
Plasma IGF-I levels and cognitive performance in older womenOlivia Okereke, Jae Hee Kang, Jing Ma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohortsShelley S Tworoger, I-Min Lee, Julie E Buring, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2007
Glioma risk in relation to serum levels of insulin-like growth factorsStefan Lönn, Peter D Inskip, Michael N Pollak, et al.
BMJ (Clinical Research Ed.)|June 2, 2012
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control studyLaurent Azoulay, Hui Yin, Kristian B Filion, et al.
Plos One|November 28, 2012
Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metforminMahvash Zakikhani, Miguel Bazile, Sina Hashemi, et al.
European Urology|May 15, 2016
Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin CancerYi Lian, Hui Yin, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 12, 2022
Biomarkers of Glucose Homeostasis and Inflammation with Risk of Prostate Cancer: A Case-Cohort StudyYing Wang, Susan M Gapstur, Christina C Newton, et al.
Cancer Causes & Control : CCC|May 10, 2017
Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trialLinda M Liao, Jonathan N Hofmann, Eunyoung Cho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Association of markers of insulin and glucose control with subsequent colorectal cancer riskSharon H Saydah, Elizabeth A Platz, Nader Rifai, et al.
BMJ (Clinical Research Ed.)|November 1, 2016
Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research DatalinkBlánaid M Hicks, Hui Yin, Oriana H Y Yu, et al.
Pageof 18